The importance of platelet phosphofructokinase (PFKP) rs6602024 polymorphism in pathogenesis of obesity
 
More details
Hide details
1
Katedra i Klinika Chorób Wewnętrznych, Diabetologii i Nefrologii, Wydział Lekarski z Oddziałem Lekarsko-Dentystycznym w Zabrzu, Śląski Uniwersytet Medyczny w Katowicach
CORRESPONDING AUTHOR
Wladyslaw Jan Grzeszczak   

Katedra i Klinika Chorób Wewnętrznych, Diabetologii i Nefrologii, Wydział Lekarski z Oddziałem Lekarsko-Dentystycznym w Zabrzu, Śląski Uniwersytet Medyczny w Katowicach, ul. 3 Maja 13/15, 41-800 Zabrze
 
Ann. Acad. Med. Siles. 2017;71:173–182
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The aim of the study was to demonstrate the potential relationship between overweight and obesity and the platelet phosphofructokinase (PFKP) rs6602024 polymorphism in patients reporting to a general practitioner at a primary care outpatient clinic.

Material and methods:
The study included a total of 438 patients from Southern Poland who reported to the general primary care outpatient clinic. PFKP rs6602024 polymorphism genotyping was conducted using fluorescence-labelled probes. The Statistica 8.0 program was used to calculate individual parameters.

Results:
Certain metabolic disorders were shown in overweight and obese people, as well as in the whole group of overweight or obese subjects. The results were compared with the outcomes obtained from people who were not overweight or obese. There were no statistically significant differences in the distribution of PFKP rs6602024 polymorphism genotypes and alleles between the study and control group. The control group showed a statistically significant difference in allele distribution between men and women. Among women, a statistically significant difference was found in the distribution of G/A alleles between the controls and overweight people as well as those overweight and obese altogether.

Conclusions:
1. Overweight and obesity are very common in people reporting to the primary care outpatient clinic. 2. The presence of PFKP rs6602024 polymorphism allele A in women is associated with an increased risk of being overweight and obese.

 
REFERENCES (16)
1.
Biela U., Pająk A., Kaczmarczyk-Chałas K. Głuszek J., Tendera M., Waśkiewicz A., Kurjata P., Wyrzykowski B. Częstość występowania nadwagi i otyłości u kobiet i mężczyzn w wielu 20–74 lat. Wyniki programu WOBASZ. Kardiol. Pol. 2005; 63 (suppl. 4): 632–636.
 
2.
Allender S., Rayner M. The burden of overweight and obesity-related ill health in the UK. Obes. Rev. 2007; 8(5): 467–473.
 
3.
Bała M., Płaczkiewicz-Jankowska E., Topór-Mądry R., Leśniak W., Wiercińska E., Szczepaniak P., Jaeschke R., Sieradzki J., Grzeszczak W., Banasiak W. Characteristics of patients with type 2 diabetes of short duration in Poland. Rationale, design and preliminary results of the ARETAEUS1 study. Pol. Arch. Med. Wewn. 2009; 119(9): 533–540.
 
4.
Bulik C.M., Sullivan P.F., Kendler K.S. Genetic and environmental contributions to obesity and binge eating. Int. J. Eat. Disord. 2003; 33(3): 293–298.
 
5.
Męczekalski B., Czyżyk A., Warenik-Szymankiewicz A. Rola genów w powstawaniu otyłości. Współczesne poglądy, patogeneza, aspekty kliniczne. Endokrynol. Otyłość 2008; 4(1): 27–37.
 
6.
Stunkard A.J., Sørensen T.I., Hanis C., Teasdale T.W., Chakraborty R., Schull W.J., Schulsinger F. An adoption study of human obesity. N. Engl. J. Med. 1986; 314(4): 193–198.
 
7.
Adamska E., Ostrowska L. Nutrigenetyka i nutrigenomika a leczenie otyłości i chorób towarzyszących. Forum Zaburzeń Metabol. 2010; 1(3): 156––167.
 
8.
Vora S., Miranda A.F., Hernandez E., Francke U. Regional assignment of the human gene for platelet-type phosphofructokinase (PFKP) to chromosome 10p: novel use of polyspecific rodent antisera to localize human enzyme genes. Hum. Genet. 1983; 63(4): 374–379.
 
9.
Nakajima H., Raben N., Hamaguchi T., Yamasaki T. Phosphofructokinase deficiency; past, present and future. Curr. Mol. Med. 2002; 2: 197–212.
 
10.
Belfiore F., Borzi V., Napoli, Rabuazzo A.M. Enzymes related to lipogenesis in the adipose tissue of obese subjects. Metabolism 1976; 25(5): 483–493.
 
11.
Moon J.S., Kim H.E., Koh E., Park S.H., Jin W.J., Park B.W., Park S.W., Kim KS. Krüppellike factor 4 (KLF4) activates the transcription of the gene for the platelet isoform of phosphofructokinase (PFKP) in breast cancer. J. Biol. Chem. 2011: 286(27): 23808–23816.
 
12.
Hannemann A. Jandrig B., Gaunitz F., Eschrich K., Bigl M. Characterization of the human P-type 6-phosphofructo-1-kinase gene promoter in neural cell lines. Gene 2005; 345(2): 237–247.
 
13.
Morgan A.R., Thompson J.M., Murphy R., Black P.N., Lam W.J., Ferguson L.R., Mitchell E.A. Obesity and diabetes genes are associated with being born small for gestational age: Results from the Auckland Birthweight Collaborative study. BMC Med. Genet. 2010; 11: 125. doi:10.1186/1471-2350-11-125.
 
14.
Liu Y.J., Liu X.G. Wang L., Dina C., Yan H., Liu J.F., Levy S., Papasian C.J., Drees B.M., Hamilton J.J., Meyre D., Delplanque J., Pei Y.F., Zhang L., Recker R.R., Froguel P., Deng HW. Genome-wide association scans identified CTNNBL1 as a novel gene for obesity. Hum. Mol. Genet. 2008; 17: 1803–1813.
 
15.
Scuteri A., Sanna S., Chen W.M., Uda M., Albai G., Strait J., Najjar S., Nagaraja R., Orrú M., Usala G., Dei M., Lai S., Maschio A., Busonero F., Mulas A., Ehret G.B., Fink A.A., Weder A.B., Cooper R.S., Galan P., Chakravarti A., Schlessinger D., Cao A., Lakatta E., Abecasis G.R. Genome-Wide Association Scan Shows Genetic Variants in the FTO Gene Are Associated with Obesity-Related Traits. PLoS Genet. 2007; 3(7): e115. doi: 10.1371/journal.pgen.0030115.
 
16.
Andreasen C.H., Mogensen M.S., Borch-Johnsen K., Sandbaek A., Lauritzen T., Sørensen T.I., Hansen L., Almind K., Jørgensen T., Pedersen O., Hansen T. Non-replication of genome-wide based associations between common variants in INSIG2 and PFKP and obesity in studies of 18,014 Danes. PLoS One. 2008; 3(8): e2872. doi: 10.1371/journal.pone.00028.
 
eISSN:1734-025X